AstraZeneca PLC (AZN) stock
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
AstraZeneca's EV/EBITDA was 39.1× on Oct 19, 2026, against 53.9× a year earlier. Over the last 5 years it ranged from 34.3× to 390.0×, with a median of 62.1×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 39.1× | −20.8 |
| 2025 | Dec 31, 2025 | 59.9× | +6.8 |
| 2024 | Dec 31, 2024 | 53.1× | −65.0 |
| 2023 | Dec 29, 2023 | 118.0× | −271.0 |
| 2022 | Dec 30, 2022 | 389.0× | +353.4 |
| 2017 | Jan 31, 2017 | 35.6× | −0.1 |
| 2016 | Dec 30, 2016 | 35.7× | – |
See a number that looks wrong?